Objective Tumor recurrence or residual regrowth are poor prognoses for pituitary adenoma
(PA). However, there is no validated and well-accepted prognostic classification of PAs to …

Giant pituitary adenomas (GPAs) have posed a formidable challenge in the management of
pituitary tumors since their original description by Jefferson in the 1940s, who documented a …

Giant prolactinomas are rare tumors characterized by their large size, compressive
symptoms, and extremely high prolactin secretion. The aim of this study is to describe our …

Purpose Prolactin (PRL)-secreting tumors are the most common functional pituitary
adenomas. They usually respond to dopamine agonist (DA) treatment, with PRL …

Introduction: Prolactinomas are the most common hormone-secreting pituitary tumors,
accounting for approximately 40% of all pituitary tumors. Infertility, gonadal and sexual …

Prolactinomas (PRLomas) constitute approximately half of all pituitary adenomas and
approximately one-fifth of them are diagnosed in males. The clinical presentation of …

Objective Invasive, medically refractory, and multiply recurrent pituitary adenomas pose a
rare, but nevertheless significant, challenge for conventional management modalities …

Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …

Purpose Giant prolactinomas, which have extremely large sizes and high prolactin (PRL)
values, are rarely seen. Although medical therapy is effective, surgical treatment is more …

Background Pediatric pituitary adenomas are rare, accounting for< 3% of all childhood
intracranial tumors, the majority of which are prolactinomas. Consequently, they are often …